BeyondSpring (BYSI) Current Leases (2019 - 2026)
BeyondSpring (BYSI) posted Current Leases of $246000.0 for Q1 2026, down 23.12% sequentially from $320000.0 in Q4 2025, and down 18.27% YoY from $301000.0 in Q1 2025.
BeyondSpring (BYSI) Current Leases (2019 - 2026) Analysis & Trends
BeyondSpring has reported Current Leases for 8 years, with the latest figure at $246000.0 in Q1 2026.
- Quarterly Current Leases fell 18.27% year-over-year to $246000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $246000.0 (down 18.27% YoY) and the FY2025 annual result came in at $320000.0, up 13.48% from the prior year.
- Current Leases eased to $246000.0 in Q1 2026 per BYSI's latest filing, from $320000.0 in the prior quarter.
- Over five years, Current Leases peaked at $966000.0 in Q4 2022 and troughed at $246000.0 in Q1 2026.
- A 5-year average of $476727.3 and a median of $313000.0 in 2025 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2023: Current Leases surged 79.55% in 2022, then slumped 73.29% in 2023.
- Over 5 years, Current Leases stood at $966000.0 in 2022, then plunged by 73.29% to $258000.0 in 2023, then gained by 9.3% to $282000.0 in 2024, then rose by 13.48% to $320000.0 in 2025, then declined by 23.12% to $246000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $246000.0, $320000.0, and $313000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | BeyondSpring | 30.22 Mn | 30.22 Mn | - | 171,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 171,000.00 |
| Mar 31, 2026 | 246,000.00 |
| Dec 31, 2025 | 320,000.00 |
| Sep 30, 2025 | 313,000.00 |
| Jun 30, 2025 | 307,000.00 |
| Mar 31, 2025 | 301,000.00 |
| Dec 31, 2024 | 282,000.00 |
| Jun 30, 2024 | 656,000.00 |
| Dec 31, 2023 | 258,000.00 |
| Jun 30, 2023 | 784,000.00 |
| Dec 31, 2022 | 966,000.00 |
| Jun 30, 2022 | 811,000.00 |
| Dec 31, 2021 | 538,000.00 |
| Sep 30, 2021 | 390,000.00 |
| Jun 30, 2021 | 486,000.00 |
| Mar 31, 2021 | 505,000.00 |
| Dec 31, 2020 | 787,000.00 |
| Sep 30, 2020 | 697,000.00 |
| Jun 30, 2020 | 649,000.00 |
| Mar 31, 2020 | 643,000.00 |